Understanding RFPL3-AS: A Protein Involved in Platelet Function and Other Cellular Processes

Target Name: RFPL3S

NCBI ID: G10737

RFPL3S

Understanding RFPL3-AS: A Protein Involved in Platelet Function and Other Cellular Processes

RFPL3-AS, short for Resorcin A-Platelet, is a protein that is expressed in platelets, which are the smallest cells in the blood. Platelets play a critical role in blood clotting and have been linked to a number of cardiovascular diseases, including heart attack, stroke, and cancer. As a result, RFPL3-AS has generated a lot of interest as a potential drug target or biomarker.

The protein RFPL3-AS is made up of 114 amino acids and has a molecular weight of 13.9 kDa. It is located on the surface of platelets and is involved in several different cellular processes, including cell adhesion, migration, and signaling.

One of the key functions of RFPL3-AS is its role in platelet function. Platelets are highly specialized cells that are involved in the formation of blood clots to help prevent bleeding in the body. RFPL3-AS plays a key role in regulating the formation and stability of platelets, as well as their ability to stick to other cells in the body.

In addition to its role in platelet function, RFPL3-AS has also been shown to be involved in a number of other cellular processes. For example, it has been shown to play a role in cell signaling, as well as in the regulation of cellular migration and adhesion.

Given its involvement in so many different cellular processes, RFPL3-AS has generated a lot of interest as a potential drug target or biomarker. Researchers are exploring the potential of using drugs that target RFPL3-AS to treat a variety of different conditions, including cardiovascular disease, cancer, and neurological disorders.

One of the challenges in studying RFPL3-AS as a drug target or biomarker is its relatively small size. While it is possible to study the effects of drugs on RFPL3-AS in cell culture or in animal models, it may be difficult to fully understand its effects in the body.

Despite these challenges, researchers are making progress in understanding the role of RFPL3-AS in different cellular processes and how it could be used as a drug target or biomarker. As the research continues, it is likely that we will learn more about the unique mechanisms of action of RFPL3-AS and how it can be used to treat a variety of different conditions.

In conclusion, RFPL3-AS is a protein that is expressed in platelets and is involved in several different cellular processes. While its small size can make it difficult to study its effects in the body, researchers are making progress in understanding its role in different processes and how it could be used as a drug target or biomarker. As the research continues, it is likely that we will learn more about the unique mechanisms of action of RFPL3-AS and how it can be used to treat a variety of different conditions.

Protein Name: RFPL3 Antisense

The "RFPL3S Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about RFPL3S comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets